Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 223

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta‐analytic approach

Sormani, Maria Pia, Bonzano, Laura, Roccatagliata, Luca, Cutter, Gary R., Mancardi, Gian Luigi, Bruzzi, Paolo · 2009 · Annals of Neurology

Abstract

Objective: The aim of this work was to evaluate whether the treatment effects on magnetic resonance imaging (MRI) markers at the trial level were able to predict the treatment effects on relapse rate in relapsing‐remitting multiple sclerosis. Methods: We used a pooled analysis of all the published randomized, placebo‐controlled clinical trials in relapsing‐remitting multiple sclerosis reporting data both on MRI variables and relapses. We extracted data on relapses and on MRI “active” lesions. A regression analysis weighted on trial size and duration was performed to study the relation between the treatment effect on relapses and the treatment effect on MRI lesions. We validated the estimated relation on an independent set of clinical trials satisfying the same inclusion criteria but with a control arm other than placebo. Results: A set of 23 randomized, double‐blind, placebo‐controlled trials in relapsing‐remitting multiple sclerosis was identified, for a total of 63 arms, 40 contrasts, and 6,591 patients. A strong correlation was found between the effect on the relapses and the effect on MRI activity. The adjusted R 2 value of the weighted regression line was 0.81. The regression equation estimated using the placebo‐controlled trials gave a satisfactory prediction of the treatment effect on relapses when applied to the validation set. Interpretation: More than 80% of the variance in the effect on relapses between trials is explained by the variance in MRI effects. Smaller and shorter phase II studies based on MRI lesion end points may give indications also on the effect of the treatment on relapse end points. Ann Neurol 2009;65:268–275

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21606

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 223

Metadata

Authors
Sormani, M. P., Bonzano, L., Roccatagliata, L., Cutter, G. R., Mancardi, G. L., & Bruzzi, P.
Venue
Annals of Neurology
Publisher
Wiley
Published
2009-03
Volume
65
Issue
3
Pages
268-275
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2118277450
Cited by
223
References
3
FWCI
18.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta‐analytic approach. https://app.cochat.ai/papers/10.1002/ana.21606
The paper
Sormani, M. P., Bonzano, L., Roccatagliata, L., Cutter, G. R., Mancardi, G. L., & Bruzzi, P. (2009). Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta‐analytic approach. Annals of Neurology. https://doi.org/10.1002/ana.21606

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.